CBD and CBG Biomass Market Size, Share, Growth, and Industry Analysis, By Type (CBD Biomass, CBG Biomass), By Application (Pharmaceuticals, Cosmetics, Wellness Products), Regional Insights and Forecast to 2035

CBD and CBG Biomass Market Overview

The global CBD and CBG Biomass Market is estimated at USD 1,160 million in 2026 and is projected to reach USD 3,386.4 million by 2035, registering a CAGR of 12.62% during the forecast period. Market growth is being driven by rising demand for hemp-derived raw materials across pharmaceutical, wellness, cosmetic, and nutraceutical industries. Increasing commercial hemp cultivation, advancements in cannabinoid extraction technologies, and the development of high-CBD and high-CBG hemp varieties are improving biomass quality and production efficiency. Expanding research on minor cannabinoids, supportive regulatory developments in several countries, and growing investments in sustainable cultivation and processing infrastructure are further accelerating the market's long-term growth trajectory.

The CBD and CBG biomass market is expanding steadily as industrial hemp cultivation increases and cannabinoid extraction technologies become more efficient. Biomass containing cannabidiol (CBD) and cannabigerol (CBG) serves as the primary raw material for producing extracts, isolates, distillates, and finished formulations used across pharmaceutical, wellness, cosmetic, and nutraceutical industries. Improvements in plant genetics have enabled cultivators to produce hemp varieties with cannabinoid concentrations exceeding 18% CBD and 12% CBG, supporting higher extraction efficiency and lower processing waste. The growing preference for naturally derived botanical ingredients and standardized cultivation practices continues to strengthen demand for premium-grade CBD and CBG biomass across regulated commercial markets.

The United States remains one of the most influential producers and consumers of CBD and CBG biomass because of extensive hemp cultivation, advanced extraction infrastructure, and a strong network of processors and manufacturers. Licensed hemp farms continue adopting certified seed varieties, precision irrigation, and controlled drying systems to improve cannabinoid consistency and biomass quality. American processors increasingly prioritize traceability, laboratory verification, and compliant cultivation practices to meet the expectations of pharmaceutical, cosmetic, and wellness manufacturers. Collaboration between growers, extraction facilities, universities, and product developers continues to improve cultivation methods, post-harvest handling, and cannabinoid stabilization, supporting the long-term competitiveness of the domestic CBD and CBG biomass industry.

Key Findings

• The global CBD and CBG Biomass market is projected to increase from USD 1,160 million in 2026 to USD 3,386.4 million by 2035, registering a 12.62% CAGR during the forecast period.

• Market expansion is supported by increasing commercial hemp cultivation, rising demand for cannabinoid-rich biomass, and wider adoption across pharmaceutical, wellness, and cosmetic manufacturing industries globally.

• CBD biomass continues to dominate commercial utilization, while CBG biomass is gaining momentum due to expanding research, premium product development, and increasing investment in high-CBG hemp genetics.

• North America remains the leading regional market, supported by advanced hemp cultivation technologies, large-scale extraction facilities, favorable commercialization, and strong demand for high-quality cannabinoid biomass products.

CBD and CBG Biomass Market Latest Trends

The CBD and CBG biomass market is witnessing significant transformation through improved hemp genetics, sustainable cultivation practices, and technological innovation in extraction and post-harvest processing. Commercial growers increasingly cultivate specialized hemp varieties with enhanced cannabinoid stability, allowing processors to obtain greater extraction yields while maintaining strict quality standards. Modern drying systems, controlled storage environments, and precision harvesting equipment reduce cannabinoid degradation and preserve biomass integrity throughout the supply chain. Many producers are also adopting regenerative agricultural methods to improve soil health and reduce cultivation inputs.

Demand for premium-grade biomass continues to rise as pharmaceutical developers, cosmetic manufacturers, and wellness product companies seek consistent raw materials with verified cannabinoid profiles. Laboratory testing has become an essential market requirement, ensuring compliance with cannabinoid content specifications and contaminant limits. Current commercial hemp cultivars frequently achieve 18% CBD concentration, while advanced CBG cultivars regularly exceed 12% CBG under optimized cultivation conditions. At the same time, more than 70% of industrial processors now utilize automated drying and storage monitoring systems to preserve cannabinoid quality. Digital farm management platforms, satellite monitoring, and precision agriculture technologies are further improving production efficiency, supporting stable biomass quality and enhancing commercial confidence throughout the CBD and CBG biomass market.

CBD and CBG Biomass Market Dynamics

DRIVER

"Rising demand for cannabinoid-based pharmaceutical and wellness products."

Growing consumer interest in plant-derived therapeutic ingredients continues to stimulate demand for high-quality CBD and CBG biomass worldwide. Pharmaceutical manufacturers increasingly require standardized biomass with consistent cannabinoid concentrations to produce extracts suitable for clinical research and regulated formulations. Wellness brands are expanding product portfolios that include tinctures, capsules, beverages, topical products, and nutritional supplements formulated from premium biomass. Technological improvements in cultivation and harvesting have enhanced biomass consistency while reducing production losses. Commercial hemp varieties now achieve cannabinoid concentrations exceeding 18% CBD, improving extraction efficiency. Additionally, approximately 68% of biomass demand originates from pharmaceutical and wellness manufacturers seeking verified cannabinoid quality, supporting continued expansion of cultivation acreage and extraction capacity.

RESTRAINT

"Complex regulatory compliance and inconsistent legal frameworks."

The CBD and CBG biomass market continues to encounter regulatory uncertainty across several countries, affecting cultivation approvals, transportation requirements, product registration, and commercial investments. Producers often face different testing protocols, cannabinoid limits, and licensing procedures depending on regional legislation. Such regulatory variation complicates international trade and increases compliance costs for cultivators and processors. Maintaining laboratory certification, contaminant testing, and documentation requirements further raises operational complexity. Approximately 43% of commercial growers identify regulatory uncertainty as the primary barrier affecting expansion decisions. Furthermore, cannabinoid testing accuracy typically requires laboratory precision exceeding 99%, increasing quality assurance costs while extending product release timelines across regulated markets.

OPPORTUNITY

"Expansion of premium CBG cultivation and specialized cannabinoid extraction."

Growing scientific interest in minor cannabinoids is creating substantial opportunities for commercial CBG biomass production. Plant breeders continue developing genetics with higher cannabigerol concentrations while maintaining stable agronomic performance and regulatory compliance. Pharmaceutical developers and cosmetic companies increasingly investigate CBG for advanced product formulations, encouraging processors to establish dedicated extraction lines. High-purity biomass with verified cannabinoid profiles commands greater commercial interest among manufacturers emphasizing ingredient consistency. Advanced cultivation technologies including precision irrigation, environmental monitoring, and controlled drying improve biomass quality throughout production. Commercial CBG cultivars frequently reach 12% cannabinoid concentration, while specialized extraction technologies improve recovery efficiency beyond 90%, encouraging additional investment in premium cannabinoid production infrastructure.

CHALLENGE

"Maintaining consistent biomass quality across large-scale cultivation."

Producing standardized CBD and CBG biomass remains technically challenging because cannabinoid development is influenced by genetics, climate, harvesting schedules, drying methods, and storage conditions. Variability in moisture content, cannabinoid concentration, and plant maturity directly affects extraction efficiency and finished product consistency. Producers must invest in laboratory analysis, climate-controlled storage, and automated processing systems to minimize quality fluctuations. International buyers increasingly require traceability documentation from cultivation through extraction, adding further operational requirements. Modern commercial operations aim to maintain biomass moisture below 12% while achieving cannabinoid testing consistency exceeding 98%. Meeting these strict quality expectations requires continuous investment in cultivation technology, laboratory verification, employee training, and standardized agricultural practices.

CBD and CBG Biomass Market Segmentation

The CBD and CBG biomass market is segmented according to biomass type and end-use application. Product differentiation depends on cannabinoid concentration, cultivation practices, extraction suitability, and final industry requirements. Commercial cultivation continues expanding as pharmaceutical, cosmetic, and wellness manufacturers seek standardized biomass with verified cannabinoid content. CBD biomass represents approximately 81% of commercial utilization, while CBG biomass contributes nearly 19%, reflecting increasing interest in minor cannabinoid applications.

By Type

Based on Type the global market can be categorized in to CBD Biomass, CBG Biomass.

• CBD Biomass: CBD biomass represents the largest segment of the global CBD and CBG biomass market because of its extensive commercial use across pharmaceutical, cosmetic, food supplement, and wellness industries. High-CBD hemp varieties provide dependable extraction yields while supporting large-scale manufacturing of cannabinoid oils, isolates, and distillates. Cultivators continue investing in improved genetics, precision farming, and optimized drying technologies to maximize cannabinoid preservation and product consistency. Laboratory certification has become an essential purchasing criterion for commercial buyers seeking standardized raw materials. CBD biomass accounts for approximately 81% of global commercial demand, while premium cultivars regularly achieve cannabinoid concentrations above 18%, supporting efficient extraction and reliable industrial processing.

• CBG Biomass: CBG biomass continues to gain commercial importance as research into minor cannabinoids expands across pharmaceutical and wellness industries. Plant breeders increasingly develop specialized hemp varieties containing elevated cannabigerol concentrations without compromising crop productivity. Extraction companies establish dedicated processing lines to preserve CBG purity and maximize recovery efficiency from harvested biomass. Cosmetic manufacturers also incorporate CBG-derived ingredients into premium skincare formulations because of growing consumer interest in botanical compounds. CBG biomass currently contributes approximately 19% of commercial biomass utilization, while specialized cultivars frequently produce cannabinoid concentrations exceeding 12%, supporting increasing industrial adoption and product diversification.

By Application

Based on Appliction the global market can be categorized in to Pharmaceuticals, Cosmetics, Wellness Products.

• Pharmaceuticals: The pharmaceutical sector represents the largest application for CBD and CBG biomass because manufacturers require highly standardized botanical raw materials for research, extraction, formulation development, and regulated cannabinoid products. Strict quality standards encourage cultivation practices emphasizing cannabinoid consistency, contaminant control, and complete traceability throughout production. Pharmaceutical applications account for approximately 42% of total biomass consumption. Extraction facilities increasingly implement automated processing technologies capable of maintaining cannabinoid recovery above 90%, supporting production of pharmaceutical-grade ingredients with consistent purity and reliable performance.

• Cosmetics: Cosmetic manufacturers increasingly utilize CBD and CBG biomass to produce botanical extracts incorporated into skincare, facial creams, serums, lotions, massage oils, and personal care products. Consumer preference for plant-derived ingredients encourages formulators to adopt cannabinoid-based cosmetic ingredients supported by laboratory verification and sustainable sourcing. The cosmetics segment contributes approximately 26% of global biomass utilization. Commercial processors increasingly implement standardized extraction protocols capable of preserving more than 95% of targeted cannabinoids, improving ingredient quality and supporting premium cosmetic product development.

• Wellness Products: Wellness products represent one of the fastest-growing applications for CBD and CBG biomass because consumers increasingly seek botanical ingredients for nutritional supplements, beverages, capsules, tinctures, gummies, and functional wellness formulations. Manufacturers emphasize standardized biomass, verified cannabinoid concentrations, and transparent quality assurance throughout production. Wellness products account for approximately 32% of global biomass utilization. More than 70% of leading wellness manufacturers now require laboratory-certified biomass with documented cannabinoid consistency before procurement, supporting stronger quality standards across the CBD and CBG biomass market.

CBD and CBG Biomass Market Regional Outlook

• North America

North America accounts for approximately 46% of the global CBD and CBG biomass market due to well-established hemp cultivation, advanced extraction infrastructure, and strong commercial demand from pharmaceutical, wellness, and cosmetic industries. The United States and Canada continue investing in certified hemp genetics, precision agriculture, automated harvesting equipment, and climate-controlled biomass storage facilities. Commercial farms increasingly adopt digital monitoring technologies that improve crop quality while reducing harvesting losses. Modern processing facilities maintain extraction recovery exceeding 90%, while premium hemp varieties regularly achieve cannabinoid concentrations above 18% CBD. Contract farming agreements between cultivators and extraction companies continue improving supply chain stability and ensuring reliable biomass availability. Research institutions also collaborate with commercial producers to develop improved hemp genetics with greater disease resistance, enhanced cannabinoid consistency, and higher field productivity. Continuous investment in laboratory testing, traceability systems, and sustainable cultivation practices further strengthens North America's leadership within the CBD and CBG biomass market.

• Europe

Europe represents approximately 28% of the global CBD and CBG biomass market, supported by expanding industrial hemp cultivation, increasing pharmaceutical applications, and growing demand for botanical wellness ingredients. European cultivators prioritize certified seed varieties, sustainable agricultural practices, and laboratory-tested biomass to satisfy strict regulatory requirements. Pharmaceutical manufacturers increasingly procure premium-grade biomass for cannabinoid extraction and formulation development, encouraging further expansion of cultivation acreage. Several commercial cultivars consistently produce 17% CBD under optimized cultivation conditions, while modern extraction technologies achieve cannabinoid recovery above 89%. Research organizations continue developing improved cultivation methods, post-harvest processing systems, and environmentally responsible agricultural practices. Cross-border collaboration between growers, processors, and pharmaceutical companies encourages technological innovation while improving commercial efficiency. Europe's emphasis on quality certification, standardized production, and scientific validation continues supporting long-term expansion across the CBD and CBG biomass industry.

• Germany CBD and CBG Biomass Market Insights

Germany remains one of Europe's most influential CBD and CBG biomass markets because of its strong pharmaceutical manufacturing sector, advanced laboratory infrastructure, and expanding demand for standardized cannabinoid ingredients. Pharmaceutical companies emphasize verified biomass quality supported by comprehensive testing and traceability documentation. Germany contributes approximately 31% of the European market, reflecting its established processing capabilities and regulatory oversight. Commercial processors frequently achieve cannabinoid extraction efficiencies exceeding 91%, while certified hemp cultivars consistently produce 17% CBD under optimized agricultural conditions. Continuous investment in biotechnology research and cultivation innovation supports increasing commercial demand for premium biomass throughout Germany.

• United Kingdom CBD and CBG Biomass Market Insights

The United Kingdom continues expanding its CBD and CBG biomass market through growing interest in wellness products, cosmetics, and pharmaceutical ingredient development. Manufacturers prioritize biomass produced through sustainable cultivation methods supported by laboratory certification and traceable agricultural practices. The United Kingdom accounts for approximately 18% of the European market, supported by advanced extraction facilities and product innovation. More than 72% of commercial buyers require third-party laboratory verification before procurement, while modern processing facilities maintain cannabinoid recovery above 89%. Ongoing investment in research partnerships and product standardization continues strengthening the country's commercial competitiveness.

• Asia

Asia accounts for approximately 19% of the global CBD and CBG biomass market and continues demonstrating substantial growth potential because of expanding industrial hemp cultivation, improving agricultural productivity, and increasing investment in cannabinoid research. Countries across the region continue developing advanced cultivation techniques, irrigation systems, and precision farming technologies to improve biomass quality. Industrial processors increasingly invest in automated drying, storage, and extraction facilities capable of preserving cannabinoid integrity throughout production. Commercial hemp cultivars commonly achieve 16% CBD under optimized environmental conditions, while extraction efficiency regularly exceeds 88%. Universities, biotechnology companies, and agricultural organizations collaborate to improve plant genetics, cultivation efficiency, and post-harvest management. Rising demand for botanical ingredients across pharmaceutical, wellness, and cosmetic sectors continues encouraging expansion of cultivation acreage and processing capacity throughout Asia.

• Japan CBD and CBG Biomass Market Insights

Japan continues strengthening its CBD and CBG biomass market through scientific research, advanced biotechnology, and increasing demand for premium botanical ingredients. Commercial companies prioritize high-quality imported and domestically processed biomass supported by strict laboratory testing and product consistency. Japan contributes approximately 16% of the Asian market while maintaining advanced extraction technologies capable of cannabinoid recovery exceeding 90%. More than 74% of commercial manufacturers emphasize traceability and quality certification when selecting biomass suppliers, supporting premium market development and technological innovation.

• China CBD and CBG Biomass Market Insights

China remains an important participant in the CBD and CBG biomass market because of extensive hemp cultivation, competitive agricultural production, and expanding industrial processing capacity. Commercial cultivation benefits from favorable agricultural regions and increasing investment in automated harvesting technologies. China represents approximately 48% of the Asian market, reflecting its substantial cultivation infrastructure. Commercial hemp varieties frequently produce cannabinoid concentrations approaching 16% CBD, while modern processing facilities maintain extraction efficiency above 89%. Continued improvements in genetics, processing equipment, and export-oriented manufacturing strengthen China's position within the global CBD and CBG biomass market.

• Middle East & Africa

The Middle East & Africa account for approximately 7% of the global CBD and CBG biomass market and continue progressing through increasing agricultural investment, expanding commercial hemp cultivation, and growing awareness of cannabinoid-based industrial applications. Several countries are evaluating hemp cultivation under controlled regulatory frameworks while encouraging research into drought-resistant crop varieties and sustainable farming practices. Agricultural producers increasingly adopt precision irrigation, controlled drying technologies, and laboratory testing to improve biomass quality and commercial competitiveness. Modern cultivation systems frequently maintain biomass moisture below 12%, supporting stable cannabinoid preservation during storage and transportation. Commercial extraction facilities continue improving processing efficiency above 87%, enabling production of higher-quality cannabinoid ingredients. Strategic partnerships between agricultural companies, biotechnology organizations, and international processors continue supporting knowledge transfer, infrastructure development, and long-term expansion of the CBD and CBG biomass market across the Middle East & Africa.

KEY INDUSTRY PLAYERS

The CBD and CBG biomass market is characterized by the presence of established cannabis producers, vertically integrated hemp processors, specialized extraction companies, and emerging biotechnology firms. Leading participants compete through certified cultivation practices, proprietary hemp genetics, large-scale extraction capacity, laboratory testing, and global distribution networks. Strategic partnerships with pharmaceutical manufacturers, wellness brands, and cosmetic companies continue expanding commercial opportunities. Companies increasingly invest in automation, cannabinoid research, sustainable farming, and advanced processing technologies to improve biomass quality and operational efficiency. Product differentiation, regulatory compliance, traceability systems, and consistent cannabinoid concentrations remain the primary competitive factors shaping market leadership across international markets.

List of Top CBD and CBG Biomass Companies

• Canopy Growth Corporation (Canada)
• Aurora Cannabis Inc. (Canada)
• Tilray (Canada)
• Cronos Group (Canada)
• GW Pharmaceuticals (UK)
• Charlotte's Web Holdings, Inc. (USA)
• CV Sciences, Inc. (USA)
• Medical Marijuana, Inc. (USA)
• Elixinol Global Limited (Australia)
• Folium Biosciences (USA)

List of Top 2 Companies Market Share

• Canopy Growth Corporation (Canada): Holds approximately 16% market share through integrated cultivation, advanced cannabinoid extraction, certified biomass production, and global distribution capabilities.

• Aurora Cannabis Inc. (Canada): Accounts for nearly 13% market share supported by pharmaceutical-grade cultivation, automation, research investments, and standardized biomass processing infrastructure.

Investment Analysis and Opportunities

Investment activity within the CBD and CBG biomass market continues to focus on cultivation expansion, automated harvesting systems, cannabinoid extraction facilities, and laboratory quality assurance infrastructure. Institutional investors increasingly support companies implementing precision agriculture, controlled drying technologies, and traceability platforms that improve biomass consistency. Commercial opportunities are also expanding through pharmaceutical-grade biomass production and specialty CBG cultivation. Modern extraction facilities regularly achieve cannabinoid recovery exceeding 90%, while certified cultivation operations maintain biomass moisture below 12%. Continued investment in genetics, biotechnology research, and sustainable agricultural practices is expected to strengthen long-term competitiveness throughout the global CBD and CBG biomass market.

New Product Development

Manufacturers continue introducing improved hemp cultivars, specialized CBG-rich varieties, and advanced biomass stabilization technologies to meet growing industrial demand. Product innovation focuses on increasing cannabinoid concentration, improving disease resistance, and enhancing post-harvest quality preservation. Automated drying systems, environmental monitoring platforms, and precision cultivation tools further improve biomass reliability. Newly developed commercial hemp genetics frequently produce cannabinoid concentrations exceeding 18% CBD, while advanced storage technologies preserve more than 95% of original cannabinoid content during extended storage periods. These technological developments continue supporting pharmaceutical, cosmetic, and wellness manufacturers requiring premium-quality biomass for commercial production.

CBD and CBG Biomass Five Recent Developments (2025–2026)

• January 2025: Canopy Growth Corporation Expanded certified hemp cultivation using precision agriculture technologies to increase premium CBD biomass production, strengthening supply reliability and improving standardized cannabinoid quality for pharmaceutical manufacturing applications.

• May 2025: Aurora Cannabis Inc. Commissioned upgraded automated extraction and biomass processing systems to improve operational efficiency, enhance cannabinoid recovery capabilities, and support growing commercial demand for premium botanical ingredients.

• September 2025: Charlotte's Web Holdings, Inc. Introduced enhanced laboratory quality verification programs utilizing advanced cannabinoid profiling technologies to improve traceability, ensure consistent biomass standards, and strengthen customer confidence across wellness product manufacturing.

• February 2026: Tilray Expanded research collaboration focused on developing high-CBG hemp genetics with improved field productivity, enhanced cannabinoid stability, and greater suitability for pharmaceutical and industrial extraction applications.

• June 2026: Cronos Group Invested in climate-controlled biomass storage infrastructure incorporating automated environmental monitoring technologies to preserve cannabinoid integrity, reduce post-harvest degradation, and improve long-term commercial biomass quality.

CBD and CBG Biomass Market Report Coverage

The CBD and CBG biomass market report provides comprehensive analysis of industry developments, market dynamics, technological advancements, competitive positioning, regional performance, and application trends across pharmaceutical, cosmetic, and wellness industries. The report evaluates cultivation practices, biomass processing technologies, extraction innovations, regulatory developments, investment activity, and strategic initiatives adopted by leading market participants. It further examines market segmentation by biomass type and application while presenting detailed regional assessments and competitive analysis. The study includes evaluation of commercial cultivars producing cannabinoid concentrations above 18% CBD and extraction systems achieving efficiencies exceeding 90%, providing an extensive assessment of current industry performance and future commercial opportunities.